United States President Donald Trump has announced that his Administration has reached an agreement with the Kodak company to allow the company to manufacture medicines.
The deal is made possible by the Defense Production Law , a Cold War regulation that it activated in late March and gives it "powers of war" to accelerate national production of medical supplies to combat the coronavirus pandemic .
"With this agreement, my Administration is making use of the Defense Production Law to provide a loan of 765 million dollars (almost 653 million euros) to support the launch of Kodak pharmaceuticals, " said Trump at a conference call. release at the White House.
Thus, Kodak will produce generic pharmaceutical assets , as reported by the CNN television network. "Using advanced manufacturing techniques, Kodak will also make the key starting materials, which are the building blocks of many drugs, in a way that is both cost-competitive and environmentally friendly," he detailed.
The president has described the agreement as "one of the most important in the history of the pharmaceutical industry in the United States" and has recognized that, for Kodak, which is dedicated to the production of photographic equipment, it is a "different field "
The United States is the country in the world most affected by the coronavirus pandemic . So far, it has confirmed more than 4.3 million cases, including nearly 150,000 deaths.
According to the criteria of The Trust Project
Know more- Donald Trump
- U.S
- Business
- economy
Covid telecommuting suspends payments to Brooks Brothers, the store of US presidents
EconomyBarcelona begins the coronavirus summer with only 37 hotels open and 10% of seats occupied
TechTwitch bans Donald Trump for posting hateful content
See links of interest
- Last News
- Programming
- English translator
- Work calendar
- Daily horoscope
- Santander League Ranking
- League calendar
- TV Movies
- Cut notes 2019
- Themes